Clinical-stage Opportunity Position 9 Meters Biopharma as a specialized partner for rare or debilitating GI diseases with a focus on regulatory milestones such as Pre-IND meetings and IND-enabling studies, presenting avenues for advisory, clinical development collaboration, or joint ventures to accelerate pipeline progress.

Strategic Partnerships Leverage their collaboration history with Gustave Roussy to propose additional international academic or oncology/gastroenterology center partnerships, enabling access to diverse patient populations, co-development opportunities, and expanded trial sites.

Funding Levers Acknowledge their recent debt financing and lean staffing; propose early-stage financing options, grant support, or strategic investor introductions to sustain preclinical and clinical programs, as well as services around financial planning for later-stage fundraising.

Commercial Readiness Explore preparatory commercial strategy support for potential obesity-related indications targeted by NM-136, including market access planning, pricing strategy, and payer engagement frameworks aligned with upcoming regulatory milestones.

Tech-enabled Advantage Highlight opportunities to augment their outreach and IA/IR capabilities using their existing tech stack (SEO, content management, CDN) to accelerate sponsor branding, patient recruitment messaging, and investor communications, while offering digital optimization services for trial awareness and site engagement.